Alliancebernstein L.P. Novartis Ag Transaction History

Alliancebernstein L.P.

  • $280 Billion
  • Q4 2024

A detailed history of Alliancebernstein L.P. transactions in Novartis Ag stock. As of the latest transaction made, Alliancebernstein L.P. holds 47,158 shares of NVS stock, worth $5.26 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
47,158
Previous 34,974 34.84%
Holding current value
$5.26 Million
Previous $4.02 Million 14.07%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
BUY
$96.78 - $117.18 $1.18 Million - $1.43 Million
12,184 Added 34.84%
47,158 $4.59 Million
Q3 2024

Nov 14, 2024
BUY
$106.13 - $120.89 $1.31 Million - $1.5 Million
12,367 Added 54.7%
34,974 $4.02 Million
Q2 2024

Aug 14, 2024
SELL
$92.57 - $107.37 $2.79 Million - $3.24 Million
-30,176 Reduced 57.17%
22,607 $2.41 Million
Q1 2024

May 14, 2024
SELL
$95.27 - $108.47 $699,948 - $796,929
-7,347 Reduced 12.22%
52,783 $5.11 Million
Q4 2023

Feb 14, 2024
BUY
$92.27 - $101.54 $710,755 - $782,162
7,703 Added 14.69%
60,130 $6.07 Million
Q3 2023

Nov 14, 2023
BUY
$94.73 - $105.13 $1.92 Million - $2.13 Million
20,220 Added 62.78%
52,427 $5.34 Million
Q2 2023

Aug 15, 2023
BUY
$92.52 - $104.91 $585,466 - $663,870
6,328 Added 24.45%
32,207 $3.25 Million
Q1 2023

May 15, 2023
SELL
$80.03 - $92.81 $69,546 - $80,651
-869 Reduced 3.25%
25,879 $2.38 Million
Q4 2022

Feb 14, 2023
BUY
$75.55 - $92.52 $13,674 - $16,746
181 Added 0.68%
26,748 $2.43 Million
Q3 2022

Nov 15, 2022
BUY
$74.61 - $87.26 $41,333 - $48,342
554 Added 2.13%
26,567 $2.02 Million
Q2 2022

Aug 15, 2022
SELL
$80.52 - $93.75 $169,414 - $197,250
-2,104 Reduced 7.48%
26,013 $2.2 Million
Q1 2022

May 13, 2022
SELL
$80.11 - $90.62 $64,088 - $72,496
-800 Reduced 2.77%
28,117 $2.47 Million
Q4 2021

Feb 14, 2022
SELL
$79.7 - $88.13 $12,273 - $13,572
-154 Reduced 0.53%
28,917 $2.53 Million
Q3 2021

Nov 10, 2021
SELL
$81.78 - $95.14 $18,809 - $21,882
-230 Reduced 0.78%
29,071 $2.38 Million
Q2 2021

Jul 30, 2021
SELL
$85.24 - $94.15 $3.8 Million - $4.19 Million
-44,546 Reduced 60.32%
29,301 $2.67 Million
Q1 2021

May 06, 2021
BUY
$83.5 - $98.47 $3.49 Million - $4.12 Million
41,805 Added 130.47%
73,847 $6.31 Million
Q4 2020

Feb 08, 2021
BUY
$78.07 - $94.43 $67,842 - $82,059
869 Added 2.79%
32,042 $3.03 Million
Q3 2020

Nov 12, 2020
BUY
$82.14 - $91.0 $106,453 - $117,936
1,296 Added 4.34%
31,173 $2.71 Million
Q2 2020

Aug 13, 2020
BUY
$80.93 - $91.1 $84,005 - $94,561
1,038 Added 3.6%
29,877 $2.61 Million
Q1 2020

May 14, 2020
SELL
$70.67 - $99.01 $49,044 - $68,712
-694 Reduced 2.35%
28,839 $2.38 Million
Q4 2019

Feb 18, 2020
BUY
$84.35 - $95.37 $36,101 - $40,818
428 Added 1.47%
29,533 $2.8 Million
Q3 2019

Nov 14, 2019
BUY
$85.54 - $94.26 $53,890 - $59,383
630 Added 2.21%
29,105 $2.53 Million
Q2 2019

Aug 14, 2019
SELL
$75.4 - $92.8 $6.42 Million - $7.91 Million
-85,205 Reduced 74.95%
28,475 $2.6 Million
Q1 2019

May 14, 2019
BUY
$75.32 - $86.15 $1.79 Million - $2.05 Million
23,747 Added 26.41%
113,680 $10.9 Million
Q4 2018

Feb 13, 2019
SELL
$73.66 - $82.02 $5.62 Million - $6.26 Million
-76,324 Reduced 45.91%
89,933 $7.72 Million
Q3 2018

Nov 08, 2018
BUY
$66.94 - $77.43 $7.65 Million - $8.85 Million
114,318 Added 220.1%
166,257 $14.3 Million
Q2 2018

Aug 13, 2018
SELL
$64.91 - $73.36 $89,056 - $100,649
-1,372 Reduced 2.57%
51,939 $3.92 Million
Q1 2018

May 14, 2018
SELL
$70.39 - $84.15 $81,652 - $97,614
-1,160 Reduced 2.13%
53,311 $4.31 Million
Q4 2017

Feb 13, 2018
SELL
$72.33 - $77.64 $1.26 Million - $1.35 Million
-17,449 Reduced 24.26%
54,471 $4.57 Million
Q3 2017

Nov 13, 2017
BUY
$74.14 - $77.27 $5.33 Million - $5.56 Million
71,920
71,920 $6.17 Million

Others Institutions Holding NVS

# of Institutions
1,480
Shares Held
130M
Call Options Held
1.31M
Put Options Held
1.56M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $240B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email